New syringe design makes eye injection easier for doctors
Disease control
Completed
This study tested whether a pre-filled syringe of the medicine SB11 (a biosimilar to ranibizumab) is easy for eye doctors to use. Thirty adults with wet age-related macular degeneration, macular edema from retinal vein occlusion, or myopic choroidal neovascularization received on…
Phase: PHASE2 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC